In collaboration with researchers at UCL to inform antibiotic treatment decisions for patients with COVID-19 pneumonia, by estimating patients’ risk of secondary
bacterial infection in the context of antimicrobial stewardship
Objectives:
To evaluate the impact of the COVID-19 pandemic on antimicrobial prescribing
For patients with virologically confirmed SARS-CoV-2:
o To describe patterns of antibiotic treatment
o To estimate the incidence of secondary bacterialinfection
o To describe microbiological and clinical outcomes
Original content: https://web.www.healthdatagateway.org/project/8303432227799408
